The mutant neoantigen specific T cell is a personalized immunotherapy in refractory solid tumour
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz253.054
Abstract: Abstract Background Immune checkpoint inhibitors are an important therapy. However, their essence is nonspecific and efficiency of single usage is not satisfactory. The mutant neoantigen specific T (Nas-T) cell, as an adoptive cell treatment, is… read more here.
Keywords: neoantigen; neoantigen specific; cell personalized; personalized immunotherapy ... See more keywords